Table 4.
Characteristic | Q1 (Referent) | Q2 | Q3 | Q4 | p-Trend |
---|---|---|---|---|---|
OR | OR (95% CI) | OR (95% CI) | OR (95% CI) | ||
Procalcitonin | |||||
Model a | 1.00 | 1.07 (0.51–2.21) | 1.58 (0.74–3.37) | 5.92 (2.25–15.6) | <0.001 |
Model b | 1.00 | 1.12 (0.53–2.36) | 1.75 (0.79–3.84) | 5.65 (2.14–14.9) | <0.001 |
CRP | |||||
Model a | 1.00 | 1.80 (0.87–3.74) | 2.89 (1.32–6.32) | 2.25 (1.04–4.87) | 0.034 |
Model b | 1.00 | 1.91 (0.90–4.04) | 2.92 (1.32–6.48) | 2.38 (1.08–5.25) | 0.049 |
BUN | |||||
Model a | 1.00 | 1.36 (0.65–2.85) | 1.94 (0.88–4.25) | 1.72 (0.81–3.65) | 0.22 |
Model b | 1.00 | 1.42 (0.67–2.99) | 2.08 (0.93–4.65) | 1.64 (0.77–3.49) | 0.31 |
PLT | |||||
Model a | 1.00 | 1.41 (0.63–3.16) | 0.96 (0.44–2.07) | 0.46 (0.22–0.97) | 0.010 |
Model b | 1.00 | 1.58 (0.69–3.63) | 0.96 (0.44–2.09) | 0.47 (0.22–0.998) | 0.010 |
PMN% (neutrophils) | |||||
Model a | 1.00 | 1.58 (0.76–3.29) | 1.06 (0.52–2.15) | 2.50 (1.14–5.51) | 0.12 |
Model b | 1.00 | 1.57 (0.75–3.29) | 1.07 (0.52–2.19) | 2.64 (1.17–5.93) | 0.10 |
Lym% | |||||
Model a | 1.00 | 1.20 (0.56–2.57) | 1.06 (0.49–2.28) | 0.57 (0.27–1.19) | 0.039 |
Model b | 1.00 | 1.22 (0.56–2.66) | 1.02 (0.47–2.22) | 0.55 (0.26–1.15) | 0.029 |
a Adjusted for Age and Sex b Adjusted for Age, Sex, and Race/Ethnicity.